PharmaDiagnostics, a company developing and marketing a label-free screening technology that does not require specialized equipment, reports that their SoPRano technology has won its third award. SoPRano was awarded an SLAS (Society for Laboratory Automation and Screening) New Product Award (NPA) designation at SBS 2011, the conference and exhibition highlighting pharmaceutical and biomolecular screening technologies.

“Winning our third prize in 12 months, this time from the SBS 2011 conference at which we are assessed against many multinational suppliers, is continued demonstration that SoPRano’s appeal to industry and academic experts is real and ongoing,” said Dr. David Ricketts, CEO at PharmaDiagnostics.